Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CubeSmart | CUBE | Nov 18, 2024 | 48.62 | +0.60 |
Cue Biopharma | CUE | Nov 18, 2024 | 1.10 | -11.65 |
Cullen Frost Bankers B Pref | CFR-B | Nov 18, 2024 | 19.69 | -0.30 |
Cullen/Frost Bankers | CFR | Nov 18, 2024 | 138.48 | -0.57 |
Cullinan Therapeutics | CGEM | Nov 18, 2024 | 13.45 | -2.96 |
Cullman Bancorp | CULL | Nov 18, 2024 | 9.71 | 0.00 |
Culp | CULP | Nov 18, 2024 | 5.06 | -0.20 |
Cumberland Pharmaceuticals | CPIX | Nov 18, 2024 | 1.12 | -1.75 |
Cummins | CMI | Nov 18, 2024 | 364.02 | +0.60 |
Cumulus Media A | CMLS | Nov 18, 2024 | 0.80 | +13.13 |
Curbline Properties | CURB | Nov 18, 2024 | 23.58 | 0.00 |
Curevac N.V. | CVAC | Nov 18, 2024 | 2.58 | +1.57 |
CuriosityStream | CURI | Nov 18, 2024 | 1.58 | -3.07 |
Curis | CRIS | Nov 18, 2024 | 3.80 | -3.80 |
CURRENC Group | CURR | Nov 18, 2024 | 1.96 | 0.00 |
Curtiss-Wright | CW | Nov 18, 2024 | 353.11 | -1.46 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | Nov 18, 2024 | 43.58 | +0.25 |
Cushman & Wakefield | CWK | Nov 18, 2024 | 13.93 | +0.65 |
Custom Truck One Source | CTOS | Nov 18, 2024 | 5.05 | -0.79 |
Customers Bancorp | CUBI | Nov 18, 2024 | 54.32 | -1.00 |
Customers Bancorp E Pref | CUBI-E | Nov 18, 2024 | 26.20 | +0.38 |
Customers Bancorp F Pref | CUBI-F | Nov 18, 2024 | 25.80 | +0.39 |
Cutera | CUTR | Nov 18, 2024 | 0.29 | -11.73 |
CVB Financial | CVBF | Nov 18, 2024 | 22.52 | 0.00 |
CVD Equipment | CVV | Nov 18, 2024 | 3.12 | +7.22 |
CVR Energy | CVI | Nov 18, 2024 | 19.08 | +1.38 |
Cvr Partners LP Unit | UAN | Nov 18, 2024 | 71.69 | -0.94 |
CVRx | CVRX | Nov 18, 2024 | 13.63 | -2.01 |
CVS Health | CVS | Nov 18, 2024 | 56.05 | +5.38 |
CXApp A | CXAI | Nov 18, 2024 | 1.36 | -2.16 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.